Response by Pfeffer et al to Letter Regarding Article, "Heart Failure With Preserved Ejection Fraction in Perspective"

被引：2
|
作者：
Pfeffer, Marc A. [1 ]
Shah, Amil M. [1 ]
Borlaug, Barry A. [2 ]
机构：
[1] Harvard Med Sch, Brigham & Womens Hosp, Cardiovasc Div, Boston, MA 02115 USA
[2] Mayo Clin, Dept Cardiovasc Med, Rochester, MN USA
来源：
CIRCULATION RESEARCH | 2019年 / 125卷 / 04期
关键词：
D O I：
10.1161/CIRCRESAHA.119.315591
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E26 / E26
页数：1
相关论文
共 50 条
  • [41] Letter by Brutsaert and De Keulenaer Regarding Article, "Effects of Sildenafil on Ventricular and Vascular Function in Heart Failure With Preserved Ejection Fraction"
    Brutsaert, Dirk L.
    De Keulenaer, Gilles W.
    CIRCULATION-HEART FAILURE, 2015, 8 (04) : 839 - 839
  • [42] Letter by Guazzi Regarding Article, "Right Ventricular Function in Heart Failure With Preserved Ejection Fraction: A Community-Based Study"
    Guazzi, Marco
    CIRCULATION, 2015, 132 (13) : E160 - E160
  • [43] Letter regarding the article 'Transcatheter tricuspid valve repair in the setting of heart failure with preserved or reduced left ventricular ejection fraction'
    Ahmed, Fareed
    Pimenta, Dominic
    Pasha, Temur
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (04) : 680 - 680
  • [44] Letter regarding the article 'Left ventricular volume and maximal functional capacity in heart failure with preserved ejection fraction: Size matters'
    Xie, Shiwei
    Xu, Lei
    Zhang, Fan
    Xiao, Heng
    Luo, Mingwei
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 (10) : 2297 - 2298
  • [45] Response to Letter Regarding Article, "Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved Versus Reduced Ejection Fraction"
    Santhanakrishnan, Rajalakshmi
    Wang, Na
    Larson, Martin G.
    Magnani, Jared W.
    McManus, David D.
    Lubitz, Steven A.
    Ellinor, Patrick T.
    Cheng, Susan
    Vasan, Ramachandran S.
    Lee, Douglas S.
    Wang, Thomas J.
    Levy, Daniel
    Benjamin, Emelia J.
    Ho, Jennifer E.
    CIRCULATION, 2016, 133 (23) : E692 - E693
  • [46] Response by Kosiborod et al to Letter Regarding Article, "Effects of Semaglutide on Symptoms, Function, and Quality of Life in Patients With Heart Failure With Preserved Ejection Fraction and Obesity: A Prespecified Analysis of the STEP-HFpEF Trial"
    Kosiborod, Mikhail N.
    Petrie, Mark C.
    Borlaug, Barry A.
    CIRCULATION, 2024, 150 (10) : e226 - e227
  • [47] Response by Jackson et al to Letter Regarding Article, "Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF"
    Jackson, Alice M.
    Jhund, Pardeep S.
    Solomon, Scott D.
    McMurray, John J. V.
    CIRCULATION, 2020, 142 (01) : E5 - E6
  • [48] Response by Unlu et al to Letter Regarding Article, "Polypharmacy in Older Adults Hospitalized for Heart Failure"
    Unlu, Ozan
    Levitan, Emily B.
    Maurer, Mathew S.
    Safford, Monika M.
    Lachs, Mark S.
    Goyal, Parag
    CIRCULATION-HEART FAILURE, 2021, 14 (03) : 429 - 430
  • [49] Letter by Weir Regarding Article, "Effects of Semaglutide on Symptoms, Function, and Quality of Life in Patients With Heart Failure With Preserved Ejection Fraction and Obesity"
    Weir, Robin A. P.
    CIRCULATION, 2024, 150 (10) : e224 - e225
  • [50] Response by Di Tullio et al to Letter Regarding Article, "Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure: Data From the Warfarin Versus Aspirin in Reduced Ejection Fraction Trial"
    Di Tullio, Marco R.
    Thompson, John L. P.
    Homma, Shunichi
    STROKE, 2016, 47 (12) : E273 - E273
12345